CVS Health Corporation
CVS
Positions held
Your positionsCVS isn't in your positions.
Add it to see shares, cost, and P&L here.
Bull / bear case
Site-generated summary from fundamentals, news, and score — not investment advice. As of 2026-10-07.
- CVS Health Corporation is strategically positioned in the healthcare plans industry, leveraging its extensive network and diversified services to capture market share.
- Revenue increased by 6% compared to the prior quarter, reaching $106.1 billion.
- Gross margin was 14.8%, although it decreased from 15.6% in the previous quarter.
- The healthcare plans industry faces regulatory pressures that could impact profitability and operational flexibility for companies like CVS.
- The operating margin has declined to 4.4% in the latest quarter from 4.7% in the previous quarter.
- Net income for the most recent quarter was $2.979 billion, showing only a slight increase from $2.943 billion in the prior quarter.
Fundamentals
| Market cap | $112.29B | Enterprise value | $174.84B | Trailing P/E | 23.11 | Forward P/E | 10.29 |
| PEG | 0.21 | Price / book | 1.41 | Beta | 0.60 | Dividend yield | 3.03% |
| Revenue growth | 7.1% | Earnings growth | 188.8% | Gross margin | 13.6% | Operating margin | 3.9% |
| Profit margin | 1.2% | ROE | 6.2% | ROA | 3.0% | Debt / equity | 0.96 |
| Current ratio | 0.87 | Free cash flow | $8.08B | Analyst recommendation | strong_buy | Mean target | $115.76 |
| 52w high | $110.68 | 52w low | $69.51 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | |
|---|---|---|---|---|---|
| Revenue | $106.1B | $100.4B | $105.7B | $102.9B | $98.9B |
| Op margin | 4.4% | 4.7% | 2.0% | 2.4% | 2.4% |
| Net income | $3.0B | $2.9B | $2.9B | -$4.0B | $1.0B |
| Gross margin | 14.8% | 15.6% | 12.8% | 13.4% | 13.7% |
| Gross profit | $15.7B | $15.6B | $13.6B | $13.8B | $13.6B |
| Operating income | $4.7B | $4.7B | $2.1B | $2.5B | $2.4B |
- Revenue +6% vs prior quarter ($106.1B vs $100.4B).
- Gross margin 14.8% (was 15.6% prior quarter).
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $402.1B | $372.8B | $357.8B | $322.5B | — |
| Op margin | 2.6% | 2.6% | 4.1% | 5.1% | — |
| Net income | $1.8B | $4.6B | $8.3B | $4.3B | — |
| Gross margin | 13.8% | 13.8% | 15.2% | 16.9% | — |
| Gross profit | $55.4B | $51.4B | $54.4B | $54.5B | — |
| Operating income | $10.4B | $9.7B | $14.6B | $16.3B | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-09 · Humana Leads Managed Care Peers in 2027 Medicare Advantage Star Ratings, Deutsche Bank Says
2026-10-09 · CVS Stock Dips After Drop in Medicare Advantage Plan Ratings
2026-10-09 · CVS Health (CVS) vs Cigna (CI): Which is a Better Stock to Buy?
2026-10-09 · Humana Says 95% of Its Medicare Advantage Members in Plans With At Least 4 Stars for 2027
2026-10-09 · Seniors Face an 18% Drop in Highly Rated Medicare Advantage Plans — But Quality Might Not Be the Cause
2026-10-09 · Humana Stock Jumps After Insurer Gets High Medicare Ratings
2026-10-09 · Humana Stock Surges After Key Medicare Advantage Plan Gets Higher Rating
2026-10-09 · Is Clover Health Stock Too Dependent On One Group Of Members?
2026-10-09 · CVS Health - Fall Into Wellness: Preventive Health Tips for Older Adults, a Q&A With Jean Reidy
2026-10-09 · Humana Soars 16% on Improved Medicare Advantage Star Ratings; CVS Slides 3%, UnitedHealth Holds Steady
Price (daily)
Full chart · RSI · MACD · patternsOn Trade and Ticker